ArticleHepatology international2017

Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant.

Mohamed Shoreibah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.